21.14
  Price8.92%   -2.07
(Pre-market: .00 -21.14 -100.00%)
Nov-22-21 07:40AM PacBio's (PACB) Collaboration to Boost Rare Disease DiagnosisZacks Investment Research
Nov-19-21 05:00AM PacBio Grants Equity Incentive Award to New EmployeeGlobeNewswire Inc.
Nov-18-21 10:29AM PacBio's (PACB) New Solution to Boost Public Health ProtectionZacks Investment Research
09:00AM PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease DiagnosisGlobeNewswire Inc.
Nov-04-21 05:15AM Prenetics 選擇 PacBio 的 Sequel IIe 為醫療護理建立個人化基因組學GlobeNewswire Inc.
Nov-03-21 08:00AM PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for HealthcareGlobeNewswire Inc.
08:34AM PacBio's (PACB) Q3 Earnings Miss Estimates, Revenues TopZacks Investment Research
Nov-03-21 04:01AM Pacific Biosciences of California (PACB) Q3 2021 Earnings Call TranscriptThe Motley Fool
12:53PM Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha
Nov-02-21 07:52AM The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To USBenzinga
Sep-24-21 04:05AM Pacific Biosciences Grants Equity Incentive Award to New EmployeeGlobeNewswire Inc.
Sep-21-21 09:18AM PacBio (PACB) Closes Omniome Buyout, Forays Into San DiegoZacks Investment Research
Sep-20-21 04:05AM Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego PresenceGlobeNewswire Inc.
Sep-18-21 09:15AM A Second Week of Declines as September ContinuesZacks Investment Research
Sep-17-21 09:15AM A Second Week of Declines as September Continues Investing.com
Sep-06-21 09:30AM 5 Largest US M&A Deals In Q2: Railways, Health Care, REITS And MoreBenzinga
Sep-03-21 09:00AM Pacific Biosciences of California, Inc. to Present at Upcoming Investor ConferencesGlobeNewswire Inc.
Sep-02-21 11:31AM Pacific Biosciences (PACB) Down 0.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research
Aug-23-21 10:11AM Here's Why You Should Retain PacBio (PACB) Stock For NowZacks Investment Research
Aug-11-21 06:00AM What Does the Future Look Like for Illumina Stock?The Motley Fool
Aug-06-21 09:15AM S&P, NASDAQ Set New Highs While Waiting for Jobs ReportZacks Investment Research
Aug-05-21 12:36PM Are Penny Stocks Worth It? 5 That Deserve Your Attention NowPennyStocks
09:15AM S&P Off Record High, Dow Down 300 Points as Jobs Data BeginsZacks Investment Research
Aug-04-21 09:15AM S&P Off Record High, Dow Down 300 Points as Jobs Data BeginsInvesting.com
12:38PM Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: BloombergBenzinga
Aug-04-21 11:26AM PacBio's (PACB) Q2 Earnings Miss Estimates, Revenues TopZacks Investment Research
09:31AM Pacific Biosciences of California (PACB) Q2 2021 Earnings Call TranscriptThe Motley Fool
Aug-04-21 06:45AM $5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 YearsThe Motley Fool
Aug-03-21 04:05AM Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial ResultsGlobeNewswire Inc.
Jul-30-21 06:35AM 3 Things About Illumina That Smart Investors KnowThe Motley Fool
Jul-28-21 04:05AM Pacific Biosciences Grants Equity Incentive Award to New EmployeeGlobeNewswire Inc.
Jul-27-21 03:03AM Earnings Preview: Pacific Biosciences of California (PACB) Q2 Earnings Expected to DeclineZacks Investment Research
Jul-23-21 07:02AM PacBio (PACB) Enhances Sequencing Platform Via Latest BuyoutZacks Investment Research
Jul-19-21 05:20AM Bull of the Day: Exact Sciences (EXAS)Investing.com
Jul-12-21 05:55AM 3 Cathie Wood Stocks You Can Buy for Less Than $50The Motley Fool
Jul-10-21 06:12AM Where Will ARK Genomic Revolution ETF Be in 5 Years?The Motley Fool
Jun-29-21 11:12AM Pacific Biosciences (PACB)-RCIGM Tie Up for Sequencing ResearchZacks Investment Research
Jun-12-21 06:10AM Has Illumina Lost Its Shine?The Motley Fool
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distribution partners in Asia, the Middle East, and Latin America. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Cap:    |  Volume (24h):